Delivery Order V797D70052-15B10918FTB110597

This is a firm-fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Ashland to Emergent Devices, Inc. (also known as Emergent BioSolutions), a for-profit manufacturer, for the supply of NARCAN (naloxone nasal spray). The order, valued at $1,356.84, is being awarded under Emergent Devices' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and has an expected completion date of October 31, 2024. This contract...

This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices. The $904,465.44 contract is for the delivery of NALOXONE HCL 4MG/SPRAY, a medication that rapidly reverses opioid overdose and treats substance abuse. This delivery order was competed on the VHA's Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which Emergent Devices holds...

The U.S. government agency, Office of Procurement Operations, awarded a $66,870.72 firm fixed-price delivery order contract to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NALOXONE (NARCAN) NASAL SPRAY 4MG MEDICATION. The contract has an ultimate completion date of June 12, 2025. Emergent Devices holds multiple federal contracts and grant sub-awards to supply NARCAN nasal spray and other naloxone formulations to various government agencies, including the...

The Department of Justice Bureau of Prisons Management Specialty Training Center Aurora awarded a $1,697 firm fixed price delivery order against Emergent Devices Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract. Under this order, Emergent Devices will provide NARCAN nasal spray and removal of four X-ray machines to the Plymouth Meeting, Pennsylvania facility through December 2023. As the prime contractor, Emergent Devices will deliver the requested pharmaceutical and equipment...

This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The $946,261.44 delivery order contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is for a firm fixed price. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has held other contracts to supply this medication...

The Department of Veterans Affairs Veterans Health Administration awarded a Delivery Order contract to Emergent Devices, Inc. to provide NALOXONE HCL 4MG/SPRAY SOLN,SPRAY,NASAL. The $857,450.88 Firm Fixed Price contract is under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Emergent Devices, a for-profit manufacturer, will deliver the opioid overdose reversal medication to VA facilities. This contract supports the VA's healthcare mission, providing a critical substance abuse...

The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...

The Department of Homeland Security Customs and Border Protection awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of naloxone/NARCAN nasal spray. The $150,465.60 contract has an August 2019 completion date and is not set aside. Emergent Devices holds a Federal Supply Schedule pharmaceutical contract with the Department of Veterans Affairs and has also received federal grant sub-awards to support naloxone distribution efforts. This...

Mountainside Medical Equipment, Inc. has been awarded an $850 firm fixed price blanket purchase agreement by the Department of Justice Drug Enforcement Administration to supply NARCAN (naloxone HCl) nasal spray 4mg kits. The one-year agreement, which has no set-aside designation, will support the DEA's mission and allow for the purchase of opioid overdose reversal medication through December 7, 2024. Place of performance will be in Marcy, New York. As the federal law enforcement agency...

This is a federal contract award to Emergent Devices, Inc., a for-profit organization and manufacturer of goods, to provide NARCAN (naloxone nasal spray) to the Department of Homeland Security Customs and Border Protection. The contract is a Delivery Order valued at $288,456.00 and is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, which Emergent Devices holds through August 2028. The contract is not set aside. NARCAN is an overdose reversal medication that...